Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Leading Pharmaceutical Companies Financial Analyses
Venture Planning Group, Sep 2009, Pages: 130
Description
Table of Contents
Companies Mentioned
Enquire before Buying
Send to a Friend
Each company’s analysis provides:
- U.S. and international sales and operating profit estimates by division, geographic region, therapeutic category, and individual drug.
- Five-year sales and operating profit performance.
The companies analyzed in the report:
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth
Contains 130 pages and 92 tables
Customers who bought this item also bought
Analysis of Bristol Myers Squibb
Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
Bristol-Myers Squibb Co.: PharmaVitae Profile
Bristol-Myers Squibb Company
Company Analysis - Bristol-Myers Squibb Co.
Bristol-Myers Squibb Company - SWOT Analysis
PharmaVitae 2003: Bristol-Myers Squibb
Bristol-Myers Squibb: Pipeline - Products - Performance - Potential
sanofi-aventis - Pipeline - Products - Performance - Potential
PharmaVitae 2004: Bristol-Myers Squibb Global Analysis
Company Report: Bristol-Myers Squibb
Sanofi-Aventis
Top of page
All rights reserved. © Copyright 2009 Research and Markets
1
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
